What conditions must be met to apply for Class D medical device MDACS registration in Hong Kong?
Release time:2025-07-08 15:35:16 The author: source:
To apply for Class D medical device registration under Hong Kong’s Medical Device Administrative Control System (MDACS), you must satisfy a series of regulatory, technical, and administrative conditions. Class D is the highest-risk class, so the Hong Kong Department of Health (DoH) applies strict eligibility criteria.

To apply for Class D medical device registration under Hong Kong’s Medical Device Administrative Control System (MDACS), you must satisfy a series of regulatory, technical, and administrative conditions. Class D is the highest-risk class, so the Hong Kong Department of Health (DoH) applies strict eligibility criteria.

Below is a detailed list of the conditions that must be met before you can submit an MDACS registration for a Class D medical device:


✅ 1. Device Must Qualify as a Medical Device (Class D)

▸ What qualifies as Class D?

  • Devices that sustain or support life

  • Devices used in life-threatening situations

  • Devices that are implantable (e.g., pacemakers, artificial heart valves)

  • In vitro diagnostic (IVD) devices used for:

    • Screening for high-risk infectious diseases (e.g., HIV, hepatitis)

    • Blood grouping or compatibility testing

🔎 Use Technical Reference TR-003 (general MDs) or TR-006 (IVDs) to confirm the classification.


✅ 2. Local Responsible Person (LRP) Must Be Appointed

If the manufacturer is not based in Hong Kong, you must appoint a Local Responsible Person who is:

  • A registered business in Hong Kong

  • Responsible for:

    • Submitting the registration through MDIS

    • Post-market surveillance and vigilance reporting

    • Product traceability and recall management

📌 Only the LRP can submit an MDACS application on behalf of a foreign manufacturer.


✅ 3. Device Must Have Prior Regulatory Approval in a GHTF Country

The device must already be approved, cleared, or registered in at least one of the following countries/regions:

RegionAcceptable Approvals
European UnionCE Certificate (MDR/IVDR)
United StatesFDA 510(k), PMA, or De Novo
CanadaHealth Canada MDL
AustraliaTGA ARTG inclusion
JapanMHLW/PMDA Shonin approval
ChinaNMPA (formerly CFDA) approval
South KoreaMFDS certificate
SingaporeHSA registration

📄 Proof required: Certificate of Free Sale (CFS) or registration/approval certificate


✅ 4. Manufacturer Must Be ISO 13485 Certified

You must hold a valid ISO 13485:2016 Quality Management System certificate that covers:

  • The entire production and design process

  • Issued by an accredited and recognized certification body

  • The scope must match the product type


✅ 5. Compliance with Essential Principles of Safety and Performance

You must demonstrate conformity to the Essential Principles outlined in:

  • GN-01 for general medical devices

  • GN-02 for in vitro diagnostic devices

A Declaration of Conformity must be signed and submitted by the manufacturer.


✅ 6. Comprehensive Technical Documentation Must Be Available

You must be able to submit or provide the following:

Required DocumentStandard/Format
Clinical Evaluation Report (CER)Based on clinical trials, real-world data, or literature
Risk Management FilePer ISO 14971
Device DescriptionDesign, materials, components
Labeling and IFUIn English and/or Traditional Chinese
Test ReportsElectrical safety (IEC 60601), EMC, sterility, biocompatibility, etc.
Post-Market Surveillance PlanIncludes vigilance, recall, complaint handling procedures

🗂 These documents must be prepared in PDF format and submitted through the MDIS platform.


✅ 7. The Device Must Be Intended for Marketing or Distribution in Hong Kong

Even though MDACS is voluntary (as of 2025), it applies only to devices that are:

  • Distributed, sold, or used in the Hong Kong market

  • Not solely for re-export purposes

❗ Devices used only in clinical trials or not for local use do not need MDACS registration.


✅ 8. Clinical Evidence Must Be Sufficient

Because Class D devices involve high risk, the Clinical Evaluation Report must demonstrate:

  • Safety under actual use conditions

  • Clinical benefit, ideally supported by:

    • Clinical trials

    • Literature analysis

    • Equivalence to approved/predicate devices

🧪 For IVDs: You may need clinical performance data such as sensitivity, specificity, reproducibility, and validation reports.


✅ 9. Post-Market Obligations Must Be Agreed to

As part of registration, the LRP must commit to:

  • Ongoing adverse event reporting

  • Field safety corrective actions (FSCA) and recalls if necessary

  • Maintaining traceability of distributed devices in Hong Kong

  • Submitting updated documents if device design or labeling changes


📝 Summary of Conditions

ConditionRequirement
✅ Device classificationMust be confirmed as Class D
✅ Local Responsible PersonMust be appointed and registered in HK
✅ Overseas regulatory approvalCE, FDA, TGA, etc.
✅ ISO 13485 QMSCertificate must be valid and product-specific
✅ Essential principles complianceVia GN-01 / GN-02
✅ Technical documentationMust be complete and current
✅ Clinical evaluationValid and relevant data required
✅ PMS systemMust be described and in place
✅ Distribution in Hong KongProduct must be marketed locally
✅ MDIS submissionMust be done online by LRP

jonathan-borba-zNmTJzKdark-unsplash.jpg

Contact Us:

Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn